Sign in

CIK 0000872589

  • Large accelerated filer

REGENERON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
REGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NY
Entity type
Operating
EIN
133444607
Phone
+1 914-847-7000
Business address
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
Former names
REGENERON PHARMACEUTICALS INC
  1. 4 Other disposition Director disposed of 141 shares (code I)
  2. 4 Grant or award Director acquired 1,651 shares (grant or award)
  3. 4 Grant or award EVP & General Mgr, Industrial acquired 3,798 shares (grant or award)
  4. 4 Grant or award EVP Research and Development acquired 1,101 shares (grant or award)
  5. 4 Grant or award EVP Research acquired 4,129 shares (grant or award)
  6. 4 Grant or award EVP Commercial acquired 2,973 shares (grant or award)
  7. 4 Grant or award EVP General Counsel and Secret acquired 2,752 shares (grant or award)
  8. 4 Grant or award EVP Finance CFO acquired 3,853 shares (grant or award)
  9. 4 Grant or award SVP Controller acquired 1,926 shares (grant or award)
  10. 4 Open-market sale EVP Commercial sold 264 shares at $730.17 ($192,765)
  11. 4 Shares withheld for taxes EVP General Counsel and Secret gave up 492 shares (to pay taxes)
  12. 4 Shares withheld for taxes Director gave up 57 shares (to pay taxes)
  13. 4 Shares withheld for taxes EVP Research gave up 492 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP Research and Development gave up 466 shares (to pay taxes)
  15. 4 Shares withheld for taxes EVP & General Mgr, Industrial gave up 492 shares (to pay taxes)
  16. 4 Shares withheld for taxes SVP Controller gave up 247 shares (to pay taxes)
  17. 4 Open-market sale Director sold 218 shares at $779.00 ($169,822)
  18. 4 Shares withheld for taxes EVP Finance CFO gave up 2,753 shares (to pay taxes)
  19. 4 Open-market sale Director sold 100 shares at an average $758.17 ($75,817)
  20. 4 Open-market sale EVP Commercial sold 1,100 shares at $756.19 ($831,809)

Page 14 of 77 · 1,533 filings